Delivery Order SPE2DB20D9214-SPE2DB25FD4SK

Award Date 1/27/25
Potential Completion Date 2/18/25
Potential Value $18K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $18,177.78, is for the procurement of 4566735277 - PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has an ultimate completion date of January 3, 2025 and was awarded on December 11, 2024. DMS Pharmaceutical Group Inc. is a key...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $35,424.00, is for the delivery of 4,567,231 units of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, by February 27, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a wide range of branded and generic...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is valued at $25,800.72 and has an ultimate completion date of January 10, 2025. It is for the provision of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers. DMS...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract has a potential value of $16,981.44 and is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of medical supplies and pharmaceuticals to military treatment facilities...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $17,625.60 contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which allows the agency to...
This is a $17,974.20 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, with a period of performance through December 9, 2024. DMS Pharmaceutical Group Inc. holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business. The contract is for the supply of PROLASTIN C 1,000 MG/20 ML VLS, a pharmaceutical product, with a potential value of $17,223.68 and a completion date of March 18, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. is a leading pharmaceutical wholesaler that has been awarded numerous prime and...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $6,153.80 contract is for the delivery of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product, to support the medical supply needs of military healthcare facilities. The contract has an ultimate completion date of November 14, 2024. DMS Pharmaceutical Group Inc. also...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $26,764.80, is for the delivery of 4,567,362,591 units of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has an ultimate completion date of March 11, 2025. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $15,014.40, is for the provision of PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has a period of performance through March 14, 2025 and is not associated with any set-aside designation. DMS Pharmaceutical Group Inc. holds a significant Indefinite...
  • SPE2DB20D9214
    Indefinite Delivery Contract
  • SPE2DB20D9214-SPE2DB25FD4SK
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $17,712.00, is for the provision of 4567231023 ! PROLASTIN C 1,000 MG/20 ML VLS, a specialized pharmaceutical product. The contract has an ultimate completion date of February 18, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The company also holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through November 2026, which enables the agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items.

Generated 4/28/25, 9:51 AM